Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TELEFLEX INCORPORATED

(TFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Teleflex Incorporated : Announces Second Quarter 2021 Earnings Conference Call Information

07/15/2021 | 06:30am EDT

WAYNE, Pa., July 15, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 29, 2021.

To register for the conference call and receive dial-in information, please use the following link: http://www.directeventreg.com/registration/event/5188749. The call can also be accessed through a live audio webcast on the company’s website teleflex.com.

An audio replay of the call will be available beginning at 11:00 am Eastern Time on July 29, 2021 either on the Teleflex website or by telephone. The call can be accessed by dialing 800-585-8367 (U.S./Canada) or 416-621-4642 (International). The confirmation code is 5188749.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Contacts:
Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development

John Hsu, CFA
Vice President, Investor Relations
investors.teleflex.com
610-948-2836


Primary Logo

Source: Teleflex Incorporated

2021 GlobeNewswire, Inc., source Press Releases

All news about TELEFLEX INCORPORATED
09/14TELEFLEX INCORPORATED : Announces Large-Scale Analysis of Real-World Healthcare ..
AQ
09/14Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data ..
CI
09/09TELEFLEX INCORPORATED : Unveils the UroLift Advanced Tissue Control (ATC)® Syste..
AQ
09/09Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2..
CI
09/07TELEFLEX INCORPORATED : Raymond James Reinstates Teleflex at Outperform with $44..
MT
09/01Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Confe..
GL
08/30TELEFLEX INCORPORATED : New Study Provides Insights into the Biocompatibility an..
AQ
08/30Teleflex Incorporated Announces New Study Provides Insights into the Biocompa..
CI
08/26Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
GL
08/13TELEFLEX INCORPORATED : Ex-dividend day for
FA
More news
Analyst Recommendations on TELEFLEX INCORPORATED
More recommendations
Financials (USD)
Sales 2021 2 820 M - -
Net income 2021 426 M - -
Net Debt 2021 1 921 M - -
P/E ratio 2021 47,6x
Yield 2021 0,26%
Capitalization 18 045 M 18 045 M -
EV / Sales 2021 7,08x
EV / Sales 2022 6,51x
Nbr of Employees 14 000
Free-Float 97,3%
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 385,57 $
Average target price 439,25 $
Spread / Average Target 13,9%
EPS Revisions
Managers and Directors
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
Gwen Chapman Chief Compliance Officer & Vice President